NCT02186925
Recruiting
Not Applicable
A Prospective Study of Clinical Factors Affecting Disease Progression and Treatment Results of Patients With Tumors of the Prostate, Bladder and Kidney.
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Kidney Cancer
- Sponsor
- Meir Medical Center
- Enrollment
- 1000
- Locations
- 1
- Primary Endpoint
- Progression Free Survival
- Status
- Recruiting
- Last Updated
- 11 years ago
Overview
Brief Summary
Identifying clinical factors such as medication, background diseases and blood tests that effect the course of disease in cancer patients can help physicians to better decide on the patient's treatment plan. The study seeks to identify and analyze relevant clinical factors that effect the course of the disease and the results of treatment in patients with cancers of the prostate, bladder and kidney.
Investigators
Eligibility Criteria
Inclusion Criteria
- •All patients with prostate, bladder or kidney cancer that are being treated at the Meir Medical Center and are over 18 years of age.
Exclusion Criteria
- •Patients under the age of 18
Outcomes
Primary Outcomes
Progression Free Survival
Time Frame: 5 years
Univariate analysis will be used to assess the effects of clinical factors on progression free survival.
Secondary Outcomes
- Patient overall survival(5 years)
Study Sites (1)
Loading locations...
Similar Trials
Completed
Not Applicable
Retrospective Analysis Assessing Clinical Risk Factors for Cardiovascular Events and Mortality and Development of a Risk Calculator in Chronic Kidney Disease Stage 5 on DialysisChronic Kidney Disease (CKD)NCT04042350Astellas Pharma Europe Ltd.2,773
Recruiting
Not Applicable
Clinical and Laboratory Characteristics of a Population of Children and Adolescents With Newly Diagnosed Type 1 Diabetes and Insulin Requirements at OnsetType 1 Diabetes (T1D)NCT06717893IRCCS Azienda Ospedaliero-Universitaria di Bologna180
Completed
Not Applicable
A study to identify factors that affect clinical trial participation and refusal in breast cancer patients by using a questionnaireJPRN-UMIN000021243SELECT BC-CONFIRM executive committee177
Completed
Not Applicable
Factors affecting insulin dose requirements for treatment of prednisolone induced hyperglycaemia.Prednisolone induced hyperglycaemiaInsulin resistanceMetabolic and Endocrine - DiabetesMetabolic and Endocrine - Other metabolic disordersACTRN12618001211257Flinders Medical Centre50
Recruiting
Not Applicable
Risk Factors & Outcomes for Clinically Documented Infections in Pediatric Cancer Patients With Fever & NeutropeniaFebrile NeutropeniaNCT02536599Assiut University360